Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 8 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
Exercise / conversionCommon Stock | 24,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007527 · form4.xml · nonDerivative · entry 1 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 74,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · derivative · entry 7 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,453 Underlying: Common Stock · 74,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 35,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · derivative · entry 6 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,790 Underlying: Common Stock · 35,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 27,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · derivative · entry 5 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,917 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 65,308 | $0.67 | $43,756.36 |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · nonDerivative · entry 4 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,252 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 74,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · nonDerivative · entry 3 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 35,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · nonDerivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 27,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007530 · form4.xml · nonDerivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 69,387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · derivative · entry 7 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,773 Underlying: Common Stock · 69,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 33,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · derivative · entry 6 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,457 Underlying: Common Stock · 33,456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 26,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · derivative · entry 5 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,097 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Tax withholdingCommon Stock | 45,622 | $0.67 | $30,566.74 |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · nonDerivative · entry 4 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,815 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 69,387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · nonDerivative · entry 3 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 33,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:28 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 26,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007521 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantRestricted Stock Units · Derivative | 185,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005225 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,540 Underlying: Common Stock · 185,540 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantStock Option (Right to Buy) · Derivative | 185,540 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005225 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,540 Underlying: Common Stock · 185,540 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC |
McDermott WendySVP, Human Resources
|
GrantRestricted Stock Units · Derivative | 433,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005223 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,180 Underlying: Common Stock · 433,180 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC |
McDermott WendySVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 649,780 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005223 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649,780 Underlying: Common Stock · 649,780 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:21 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantRestricted Stock Units · Derivative | 502,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005221 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,060 Underlying: Common Stock · 502,060 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:21 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantStock Option (Right to Buy) · Derivative | 753,090 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005221 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753,090 Underlying: Common Stock · 753,090 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:20 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 606,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005220 · form4.xml · derivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,780 Underlying: Common Stock · 606,780 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:20 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 910,170 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005220 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 910,170 Underlying: Common Stock · 910,170 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:20 UTC |
DeFrancesco LisaVP, IR and Corp Comm
|
GrantRestricted Stock Units · Derivative | 384,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005218 · form4.xml · derivative · entry 2 DeFrancesco Lisa · CIK 0001846325 · VP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,570 Underlying: Common Stock · 384,570 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:20 UTC |
DeFrancesco LisaVP, IR and Corp Comm
|
GrantStock Option (Right to Buy) · Derivative | 576,850 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005218 · form4.xml · derivative · entry 1 DeFrancesco Lisa · CIK 0001846325 · VP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,850 Underlying: Common Stock · 576,850 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:19 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantRestricted Stock Units · Derivative | 510,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005215 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,490 Underlying: Common Stock · 510,490 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:19 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantStock Option (Right to Buy) · Derivative | 765,730 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005215 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,730 Underlying: Common Stock · 765,730 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:18 UTC |
Corrigan BrianSVP, Regulatory & QA
|
GrantRestricted Stock Units · Derivative | 448,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005213 · form4.xml · derivative · entry 2 Corrigan Brian · CIK 0002032323 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,660 Underlying: Common Stock · 448,660 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:18 UTC |
Corrigan BrianSVP, Regulatory & QA
|
GrantStock Option (Right to Buy) · Derivative | 673,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005213 · form4.xml · derivative · entry 1 Corrigan Brian · CIK 0002032323 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,000 Underlying: Common Stock · 673,000 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:17 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 480,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005212 · form4.xml · derivative · entry 2 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,710 Underlying: Common Stock · 480,710 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:17 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 721,070 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005212 · form4.xml · derivative · entry 1 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 721,070 Underlying: Common Stock · 721,070 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:16 UTC |
Exton MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 1,509,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005209 · form4.xml · derivative · entry 2 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,509,790 Underlying: Common Stock · 1,509,790 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:16 UTC |
Exton MichaelDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,264,690 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005209 · form4.xml · derivative · entry 1 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,264,690 Underlying: Common Stock · 2,264,690 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 21:09 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001127602-25-000084 · form4.xml · derivative · entry 1 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2035-01-02 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 22:41 UTC |
Cheung IvanDirector
|
GrantStock Option (Right to Buy) · Derivative | 186,685 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001127602-24-028323 · form4.xml · derivative · entry 1 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,685 Underlying: Common Stock · 186,685 shares Expires 2034-12-02 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| August 12, 2024 Filed Aug 12, 2024 12:40 UTC |
Corrigan BrianSVP, Regulatory & QA
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001127602-24-021967 · form4.xml · derivative · entry 1 Corrigan Brian · CIK 0002032323 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-08-12 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| July 08, 2024 Filed Jul 8, 2024 21:27 UTC |
WADE JEFFREY LPresident and COO
|
GrantStock Option (Right to Buy) · Derivative | 307,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001127602-24-020203 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,000 Underlying: Common Stock · 307,000 shares Expires 2034-07-08 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| July 08, 2024 Filed Jul 8, 2024 21:27 UTC |
Exton MichaelDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,675,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001127602-24-020202 · form4.xml · derivative · entry 1 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,675,000 Underlying: Common Stock · 1,675,000 shares Expires 2034-07-08 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:04 UTC |
Sullivan Diane E.Director
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015083 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:04 UTC |
Sullivan Diane E.Director
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015083 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:05 UTC |
Swain Judith LDirector
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015084 · form4.xml · derivative · entry 2 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:05 UTC |
Swain Judith LDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015084 · form4.xml · derivative · entry 1 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015082 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015082 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015080 · form4.xml · derivative · entry 2 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015080 · form4.xml · derivative · entry 1 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:02 UTC |
DEBBANE RAYMONDDirector
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015079 · form4.xml · derivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:02 UTC |
DEBBANE RAYMONDDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015079 · form4.xml · derivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:01 UTC |
BARKER SAM LDirector
|
GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015077 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:01 UTC |
BARKER SAM LDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015077 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.